Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
CN
Contact Us
Close Button
Message
Back To Top
Online Message×
Click switch
Close Button
News and Events

Featured Stories

Hot information:
Top 10 Global Clinical Research Organizations in 2021| Top 10 Global CDMO Enterprises| Preclinical Drug Development Process
Dec 23,2022
Global CDMO Catalent
Catalent, headquartered in New Jersey, has nearly 90 years of experience developing new drugs, with sales of 4 billion US dollars in 2021. The multifunctional pharmaceutical manufacturing platform in more than 50 locations worldwide provides more than 70 billion doses and 7000 million doses to more than 1,000 customers annually.
More
Global CDMO Catalent
Dec 02,2022
What is CRO,CMO,CDMO
Contract Research Organization referred to as CRO, mainly provides drug discovery, preclinical research, clinical trials, and other new drug R&D contract research services for multinational pharmaceutical companies and pharmaceutical companies. Biomedical R&D outsourcing has gradually become an indispensable link in the pharmaceutical industry chain and plays a vital role in the industrial structure.
More
What is CRO,CMO,CDMO
Oct 12,2022
Toxicity of ADC drugs
On February 3rd, Johnson & Johnson announced that it had reached a cooperation agreement with Mersana Therapeutics to jointly develop three new generation ADC drugs.
More
Toxicity of ADC drugs
Oct 11,2022
Present Situation, Challenge, Opportunity and Future of ADC
At present, a variety of antibody-coupled drugs (ADC) have been approved for the treatment of solid tumors, and have been rapidly extended to indications of multiple tumor types. For example, anti-HER2 ADC, anti-Trop-2 ADC, anti-nectin-4 ADC, etc.
More
Present Situation, Challenge, Opportunity and Future of ADC
Sep 30,2022
Medicilon Pharmacokinetic Services for First-in-Class Ubiquitination Inhibitor Development
TAK-243 was found to have significant antitumor activity. Among other things, researchers conducted in vivo efficacy experiments using the HCC-70 model through Medicilon. The results revealed a tumor growth inhibition (TGI) rate of 91%.
More
Medicilon Pharmacokinetic Services for First-in-Class Ubiquitination Inhibitor Development
Sep 29,2022
Complete Process DMPK Service Helps PROTAC Drug Development
Through the principle of PROTAC technology, medicilon, combined with R&D cases, uses the perfect in vitro ADME and in vivo PK testing platform to establish a screening and IND evaluation system on PROTAC drugs based on small molecule compound research, focusing on drug solubility, permeability, metabolic stability, metabolite identification and in vivo PK studies, etc., to help customers quickly advance the development of PROTAC drugs.
More
Complete Process DMPK Service Helps PROTAC Drug Development
Sep 15,2022
Top 10 Global CDMO Enterprises
Lonza ranks first, and China's WuXi department (WuXi AppTec + WuXi Biologics) has ranked the second position in the world. Among the top 10, two Asian companies and European companies occupy the majority.
More
Top 10 Global CDMO Enterprises
Sep 14,2022
Top 10 Global CDMO in 2022
In recent years, the global CDMO industry has maintained steady growth. In terms of revenue, Switzerland's Lonza ranks first, with sales of 5.4 billion Swiss francs in 2021, a year-on-year increase of 20%.
More
Top 10 Global CDMO in 2022
Sep 14,2022
Domestic and Foreign Pharmaceutical CDMO Industry
The MAH system has brought unprecedented opportunities and challenges to the Chinese pharmaceutical industry. Combined with the current development of the world's biopharmaceutical industry, the article will take you to understand the development pattern and current situation of the pharmaceutical CDMO industry, and understand the background of the CDMO industry development driven by policies and dividends.
More
Domestic and Foreign Pharmaceutical CDMO Industry
Sep 13,2022
Innovative drug development ideas for topical skin preparations
Equipped with corresponding transdermal and testing instruments (Such as LC-MS/MS), medicilon can provide professional and efficient services in projects involving in vitro evaluation such as compound screening, new drug submission, pharmacological changes of marketed chemical drugs, consistency evaluation, and generic drug submission.
More
Innovative drug development ideas for topical skin preparations